Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Items 601–700 of 1,005
Maintenance of human haematopoietic stem and progenitor cells in vitro using a chemical cocktail
Jiang, M., Chen, H., Lai, S., Wang, R., Qiu, Y., Ye, F., Fei, L., Sun, H., Xu, Y., Jiang, X., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0059-5 · Cited by 19
Self-citationSomatic Reprogramming—Above and Beyond Pluripotency
Meir, Y. J., & Li, G. (2021) · Cells · doi:10.3390/cells10112888 · Cited by 19
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaître, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 20
Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations
Chen, C., & Guan, M. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00967-7 · Cited by 19
Yang, J., Kaur, K., Ong, L. L., Eisenberg, C. A., & Eisenberg, L. M. (2015) · Stem Cells International · doi:10.1155/2015/270428 · Cited by 19
Stem Cell Gene SALL4 in Aggressive Hepatocellular Carcinoma: A Cancer Stem Cell-Specific Target?
Yakaboski, E., Jares, A., & Ma, Y. (2013) · Hepatology · doi:10.1002/hep.26956 · Cited by 19
Aguilera-Castrejon, A., Pasantes‐Morales, H., Montesinos, J. J., Cortés-Medina, L. V., Castro-Manrreza, M. E., Mayani, H., & Ramos‐Mandujano, G. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2086-7 · Cited by 19
Autologous Stem Cell Therapy for Inherited and Acquired Retinal Disease
Apatoff, M. B. L., Sengillo, J. D., White, E. C., Bakhoum, M. F., Bassuk, A. G., Mahajan, V. B., & Tsang, S. H. (2018) · Regenerative Medicine · doi:10.2217/rme-2017-0089 · Cited by 19
Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion
Kwon, D., Ji, M., Lee, S., Seo, K. W., & Kang, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9697-x · Cited by 18
Bioactive materials for in vivo sweat gland regeneration
Yang, X., Xiong, M., Fu, X., & Sun, X. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.07.025 · Cited by 18
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 18
A Mesenchymal stem cell Aging Framework, from Mechanisms to Strategies
Zhao, H., Zhao, H., & Ji, S. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10732-4 · Cited by 18
Generating a self-organizing kidney from pluripotent cells
Little, M. H., & Takasato, M. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000174 · Cited by 18
Mechanics of Microenvironment as Instructive Cues Guiding Stem Cell Behavior
Gupta, K., Afzal, J. M., Chang, H., Goyal, R., & Levchenko, A. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0033-9 · Cited by 18
Cheng, X., Dimou, E., Alborzinia, H., Wenke, F., Göhring, A. R., Reuter, S., Mah, N., Fuchs, H. R., Andrade-Navarro, M. A., Adjaye, J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00144 · Cited by 18
Stem Cell Therapy for Parkinson’s Disease
Han, F., & Hu, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4370-8_3 · Cited by 18
Application of Cancer Cell Reprogramming Technology to Human Cancer Research
Pan, X.-Y., Tsai, M.-H., Wuputra, K., Ku, C., Lin, W., Lin, Y., Kishikawa, S., Noguchi, M., Saito, S., Lin, C., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11703 · Cited by 18
Yavarpour‐Bali, H., Ghasemi‐Kasman, M., & Shojaei, A. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109820 · Cited by 18
What we can learn from iPSC-derived cellular models of Parkinson's disease
Caiazza, M. C., Lang, C., & Wade‐Martins, R. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.11.002 · Cited by 18
Chen, Y., Wu, B., Lin, J., Yu, D., Du, X., Sheng, Z., Yu, Y., An, C., Zhang, X., Li, Q., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.01.013 · Cited by 18
Self-citationXu, W., Li, H., Peng, L., Pu, L., Xiang, S., Li, Y., Tao, L., Liu, W., Liu, J., Xiao, Y., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.817779 · Cited by 18
Self-citationEndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment
Zhang, X., Ren, Z., & Jiang, Z. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04544-8 · Cited by 18
Self-citationLiu, G.-F., Liu, C., Guo, Y., Wang, Y., Sun, T., Xu, J., Yang, P., Ma, C., Guan, W., & Wang, C. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.355820 · Cited by 18
Self-citationLiu, S., Xu, Y., Zhou, Z., Feng, B., & Huang, H. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.01.003 · Cited by 18
Stem-Cell Therapy Advances in China
Hu, L., Zhao, B., & Wang, S. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.224 · Cited by 18
Tamanini, S., Comi, G. P., & Corti, S. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0888-0 · Cited by 18
Mishra, S., Kaçin, E., Stamatiadis, P., Franck, S., der Jeught, M. V., Mertes, H., Pennings, G., Sutter, P. D., Sermon, K., Heindryckx, B., et al. (2018) · Molecular Human Reproduction · doi:10.1093/molehr/gay007 · Cited by 18
Yu, J., Palano, G., Lim, C., Moggio, A., Drowley, L., Plowright, A. T., Bohlooly‐Y, M., Rosen, B. S., Hansson, E. M., Wang, Q., et al. (2019) · Stem Cells · doi:10.1002/stem.3012 · Cited by 18
Mitochondrial dynamics and metabolism in induced pluripotency
Prieto, J., Ponsoda, X., Belmonte, J. C. I., & Torres, J. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110870 · Cited by 18
Is it possible to save the environment and satisify consumers with artificial meat?
Hocquette, J.-F. J.-F. (2015) · Journal of Integrative Agriculture · doi:10.1016/s2095-3119(14)60961-8 · Cited by 19
Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies
Dashtban, M., Panchalingam, K. M., Shafa, M., & Ahmadian Baghbaderani, B. (2020) · Methods in Molecular Biology · doi:10.1007/7651_2020_288 · Cited by 17
Cardiac stem cells for myocardial regeneration: promising but not ready for prime time
Lader, J. M., Stachel, M., & Bu, L. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.05.009 · Cited by 17
An effective pharmacological hydrogel induces optic nerve repair and improves visual function
Wang, L., Zhang, S., Han, Y., Tang, S., Li, J., Bu, L., Zhao, D., & Deng, H. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2394-3 · Cited by 17
Self-citationManipulating cell fate through reprogramming: approaches and applications
Yagi, M., Horng, J. E., & Hochedlinger, K. (2024) · Development · doi:10.1242/dev.203090 · Cited by 17
Chemical-based epigenetic reprogramming to advance pluripotency and totipotency
Wen, S., Zheng, R., Cai, C., & Jiang, W. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01874-8 · Cited by 17
Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders
Qin, Y., & Gao, W. (2015) · Stem Cells · doi:10.1002/stem.2112 · Cited by 17
Emerging pharmacological approaches to promote neurogenesis from endogenous glial cells
Boda, E., Nato, G., & Buffo, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.129 · Cited by 17
Tang, W., Guo, R., Shen, S., Zheng, Y., Lu, Y., Jiang, M., Cui, X. J., Jiang, C., & Xie, X. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0170-z · Cited by 17
Chemically-induced osteogenic cells for bone tissue engineering and disease modeling
Yoon, J., Mandakhbayar, N., Hyun, J., Yoon, D. S., Patel, K. D., Kang, K., Shim, H., Lee, H., Lee, J., Leong, K. W., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121792 · Cited by 17
Cellular reprogramming of fibroblasts in heart regeneration
Chi, C., & Song, K. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.03.009 · Cited by 17
Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine
Jang, S.-F., Liu, W., Song, W.-S., Chiang, K.-L., Ma, H.-I., Kao, C.-L., & Chen, M.-T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033904 · Cited by 17
Kaini, R. R., Shen-Gunther, J., Cleland, J. M., Greene, W. A., & Wang, H.-C. H. (2015) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0180 · Cited by 17
Direct reprogramming and biomaterials for controlling cell fate
Kim, E., & Tae, G. (2016) · Biomaterials Research · doi:10.1186/s40824-016-0086-y · Cited by 17
Application of induced pluripotency in cancer studies
Czerwińska, P., Mazurek, S., & Wiznerowicz, M. (2018) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2018.04.005 · Cited by 17
Protein Kinases and Their Inhibitors in Pluripotent Stem Cell Fate Regulation
Lee, J., Park, Y., & Jung, H. (2019) · Stem Cells International · doi:10.1155/2019/1569740 · Cited by 17
Targeting cell plasticity for regeneration: From in vitro to in vivo reprogramming
Romanazzo, S., Lin, K., Srivastava, P., & Kilian, K. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.007 · Cited by 17
Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate Engineering
Tan, D. S., Chen, Y., Gao, Y., Bednarz, A., Wei, Y., Malik, V., Ho, D., Weng, M., Ho, S. Y., Srivastava, Y., et al. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab075 · Cited by 17
Novel cell sources for bone regeneration
Li, C., Mills, Z., & Zheng, Z. S. (2021) · MedComm · doi:10.1002/mco2.51 · Cited by 17
Parvini, M., Satarian, L., Parivar, K., Javan, M., Tondar, M., Ahmad, S., & Baharvand, H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8684-y · Cited by 17
Xiao, X., Li, N., Zhang, D., Yang, B. K., Guo, H., & Li, Y. (2016) · Cellular Reprogramming · doi:10.1089/cell.2016.0020 · Cited by 17
Self-citationReprogramming of germ cells into pluripotency
Sekita, Y., Nakamura, T., & Kimura, T. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i8.251 · Cited by 17
Lee, Y., Lee, S.-W., Jeong, D., Lee, H., Choi, N. Y., Bang, J. S., Ham, S., & Ko, K. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc22110 · Cited by 16
Ji, J., Hongju, X., Li, C., & Luo, J. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0005 · Cited by 16
Metabolic control of induced pluripotency
Sinenko, S. A., & Tomilin, A. N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1328522 · Cited by 16
Generation and characterization of giant panda induced pluripotent stem cells
Liu, Y., Zhang, S., Zou, G., An, J., Li, Y., Lin, D., Wang, D., Li, Y., Chen, J.-S., Feng, T., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn7724 · Cited by 16
Self-citationBiomaterials for pluripotent stem cell engineering: from fate determination to vascularization
Seale, N. M., & Varghese, S. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02658j · Cited by 16
In Vivo Generation of Neural Stem Cells Through Teratoma Formation
Hong, Y. J., Kim, J. S., Choi, H. W., Song, H., Park, C., & Tae, J. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0124 · Cited by 16
Ala, M., Jafari, R. M., Nematian, H., Ganjedanesh, M. R., & Dehpour, A. R. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.09.036 · Cited by 16
Regeneration through Reprogramming Adult Cell Identity in Vivo
Smith, D. K., & Zhang, C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.025 · Cited by 16
Induced pluripotent stem cells for modeling of pediatric neurological disorders
Jang, J., Quan, Z., Yum, Y. J., Song, H. S., Paek, S., & Kang, H. (2014) · Biotechnology Journal · doi:10.1002/biot.201400010 · Cited by 16
The quest for an effective and safe personalized cell therapy using epigenetic tools
Brevini, T., Pennarossa, G., Manzoni, E. F. M., Gandolfi, C. E., Zenobi, A., & Gandolfi, F. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0283-5 · Cited by 16
Chiang, M., Lin, Y., Chang, S., Shyu, W., Lu, H., & Chen, S. (2017) · Small · doi:10.1002/smll.201700703 · Cited by 16
Genomic and molecular control of cell type and cell type conversions
Fu, X., He, F., Li, Y., Shahveranov, A., & Hutchins, A. P. (2017) · Cell Regeneration · doi:10.1016/j.cr.2017.09.001 · Cited by 16
Self-citationLogie, C., & Knoch, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.71387 · Cited by 16
The Future of Direct Cardiac Reprogramming: Any GMT Cocktail Variety?
López-Muneta, L., Miranda-Arrubla, J., & Carvajal‐Vergara, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217950 · Cited by 16
Zhang, Y., Xie, X., Hu, J., Afreen, K. S., Zhang, C., Zhuge, Q., & Yang, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.546484 · Cited by 17
Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies
Salam, A., Proudfoot, L. E., & McGrath, J. A. (2014) · Annals of Medicine · doi:10.3109/07853890.2013.866441 · Cited by 16
In Vitro Differentiation and Expansion of Human Pluripotent Stem Cell-Derived Pancreatic Progenitors
Chmielowiec, J., & Borowiak, M. (2014) · The Review of Diabetic Studies · doi:10.1900/rds.2014.11.19 · Cited by 16
Hsu, C. Y. M., Walsh, T., Borys, B. S., Kallos, M. S., & Rancourt, D. E. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.04.007 · Cited by 16
Research progress and application prospects of stable porcine pluripotent stem cells
Zhang, J., Zhi, M., Gao, D., Zhu, Q., Gao, J., Zhu, G., Cao, S., & Han, J. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac119 · Cited by 15
Xiang, J., Chen, H., Zhang, H., Wu, L., Li, Y., Ji, S., Pi, W., Cui, S., Dong, L., Fu, X., et al. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.11.003 · Cited by 15
Self-citationConserved regulation of RNA processing in somatic cell reprogramming
Kanitz, A., Syed, A. P., Kaji, K., & Zavolan, M. (2019) · BMC Genomics · doi:10.1186/s12864-019-5438-2 · Cited by 15
mRNA-Driven Generation of Transgene-Free Neural Stem Cells from Human Urine-Derived Cells
Kang, P. J., Son, D., Ko, T. H., Hong, W., Yun, W., Jang, J., Choi, J., Song, G., Lee, J.-B., Kim, I. Y., et al. (2019) · Cells · doi:10.3390/cells8091043 · Cited by 15
Cong, X., Zhang, S., Batty, L. D., & Luo, J. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0234 · Cited by 15
Wang, X., Wu, J., Wang, W., Zhang, Y., He, D., Xiao, B., Zhang, H., Song, A., Xing, Y., & Li, B. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00078 · Cited by 15
Guerrero, A., Innes, A. J., Roux, P., Buisman, S. C., Jung, J., Ortet, L., Moiseeva, V., Wagner, V., Robinson, L. J., Ausema, A., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00279-9 · Cited by 15
Mechanisms for enhancing cellular reprogramming
Soufi, A. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.007 · Cited by 15
Baruselli, P. S., Batista, E. O. S., Vieira, L. M., Sales, J. N. S., Gimenes, L. U., & Ferreira, R. M. (2016) · Animal Reproduction · doi:10.21451/1984-3143-ar907 · Cited by 15
Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency
Hawkins, K., Moschidou, D., Faccenda, D., Wruck, W., Martín-Trujillo, Á., Hau, K.-L., Ranzoni, A. M., Sánchez-Freire, V., Tommasini, F., Eaton, S. D., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.014 · Cited by 15
Rodríguez-Madoz, J. R., José‐Eneriz, E. S., Rabal, O., Zapata‐Linares, N., Miranda, E., Rodríguez-Diaz, S., Porciuncula, A., Vilas‐Zornoza, A., Gárate, L., Segura, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190275 · Cited by 15
Mao, T., Han, C., Deng, R., Wei, B., Meng, P., Luo, Y., & Zhang, Y. (2018) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2018.1446229 · Cited by 15
Real‐Time Imaging of Dynamic Cell Reprogramming with Nanosensors
Wiraja, C., Yeo, D., Tham, K., Chew, S. W. T., Lim, X., & Xu, C. (2018) · Small · doi:10.1002/smll.201703440 · Cited by 15
Chen, Y., Sun, H., Yao, X., Yu, Y., Tian, T., Xu, W., Zhou, Y., & Ouyang, H. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03983-8 · Cited by 15
Shelby, H., Shelby, T., & Wernig, M. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040808 · Cited by 15
Induction of meiosis by embryonic gonadal somatic cells differentiated from pluripotent stem cells
Wang, H., Liu, L., Liu, C., Wang, L., Chen, J., Wang, H., Heng, D., Zeng, M., Liu, C., Zhou, Z., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02672-4 · Cited by 15
Self-citationExcessive Cellular Proliferation Negatively Impacts Reprogramming Efficiency of Human Fibroblasts
Gupta, M. K., Teo, A. K. K., Rao, T. N., Bhatt, S., Kleinridders, A., Shirakawa, J., Takatani, T., Hu, J. Y., Jesus, D. F. D., Windmueller, R., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0217 · Cited by 15
Babu, P. (2013) · ACS Chemical Biology · doi:10.1021/cb400784j · Cited by 15
A virus-free vector for the transfection of somatic cells to obtain IPSC
Varlı, H. S., Alkan, F., Demirbilek, M., & Türkoğlu, N. (2019) · Journal of Nanoparticle Research · doi:10.1007/s11051-019-4668-1 · Cited by 15
Recent advances and future directions in urinary system tissue engineering
Yuan, J., Suo, D., Li, P., Zhao, X., Wang, H., & Chen, B. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101600 · Cited by 14
The building blocks of embryo models: embryonic and extraembryonic stem cells
Ren, H., Jia, X., & Yu, L. (2025) · Cell Discovery · doi:10.1038/s41421-025-00780-6 · Cited by 14
Application of induced pluripotent stem cells in the conservation of endangered animals
Lou, J., Li, W., Chen, P., Chen, H., Shakoor, A., Chen, Y., Hua, J., Wang, Y., & Zhang, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04392-5 · Cited by 14
Induced Neural Lineage Cells as Repair Kits: So Close, Yet So Far Away
Mirakhori, F., Zeynali, B., Salekdeh, G. H., & Baharvand, H. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24509 · Cited by 14
And Then There Were None: No Need for Pluripotency Factors to Induce Reprogramming
Chou, B.-K., & Cheng, L. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.08.004 · Cited by 14
Cardiac reprogramming: from mouse toward man
Srivastava, D., & Berry, E. C. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.07.007 · Cited by 14
Cellular reprogramming and its application in regenerative medicine
Hong, K. (2014) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-014-0099-3 · Cited by 15
Šarić, T., Halbach, M., Khalil, M., & Er, F. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.863275 · Cited by 14
Small-molecule phenotypic screening with stem cells
Ursu, A., Schöler, H. R., & Waldmann, H. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2383 · Cited by 14
3D Printing for Cell Therapy Applications
Leberfinger, A. N., Moncal, K. K., Ravnic, D. J., & Ozbolat, I. T. (2017) · Molecular and translational medicine · doi:10.1007/978-3-319-57153-9_11 · Cited by 14
Advances in Small Molecules in Cellular Reprogramming: Effects, Structures, and Mechanisms
Zeng, J., Li, Y., Ma, Z., & Hu, M. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200621172042 · Cited by 14
Self-citationEarly developmental plasticity enables the induction of an intermediate extraembryonic cell state
Sathyanarayanan, A., Ing‐Simmons, E., Chen, R., Jeong, H., Ozguldez, H. O., Fan, R., Duethorn, B., Kim, K.-P., Kim, Y. S., Stehling, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl9583 · Cited by 14
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.